Literature DB >> 11812024

The role of nitric oxide in tissue destruction.

S B Abramson1, A R Amin, R M Clancy, M Attur.   

Abstract

Nitric oxide (NO) is synthesized via the oxidation of arginine by a family of nitric oxide synthases (NOS), which are either constitutive (ie. endothelial (ec)NOS and neuronal (nc)NOS) or inducible (iNOS). The production of nitric oxide plays a vital role in the regulation of physiological processes, host defence, inflammation and immunity. Pro-inflammatory effects include vasodilation, oedema, cytotoxicity and the mediation of cytokine-dependent processes that can lead to tissue destruction. Nitric oxide-dependent tissue injury has been implicated in a variety of rheumatic diseases, including systemic lupus erythematosus (SLE), rheumatoid arthritis and osteoarthritis. Conversely, the production of NO by endothelial cell NOS may serve a protective, or anti-inflammatory, function by preventing the adhesion and release of oxidants by activated neutrophils in the microvasculature. In this chapter we describe the multifaceted role of nitric oxide in inflammation and address the potential therapeutic implications of NOS inhibition. Copyright 2001 Harcourt Publishers Ltd.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11812024     DOI: 10.1053/berh.2001.0196

Source DB:  PubMed          Journal:  Best Pract Res Clin Rheumatol        ISSN: 1521-6942            Impact factor:   4.098


  43 in total

1.  Photoactive Ruthenium Nitrosyls: Effects of Light and Potential Application as NO Donors.

Authors:  Michael J Rose; Pradip K Mascharak
Journal:  Coord Chem Rev       Date:  2008-10-01       Impact factor: 22.315

2.  IL-6 induces regionally selective spinal cord injury in patients with the neuroinflammatory disorder transverse myelitis.

Authors:  Adam I Kaplin; Deepa M Deshpande; Erick Scott; Chitra Krishnan; Jessica S Carmen; Irina Shats; Tara Martinez; Jennifer Drummond; Sonny Dike; Mikhail Pletnikov; Sanjay C Keswani; Timothy H Moran; Carlos A Pardo; Peter A Calabresi; Douglas A Kerr
Journal:  J Clin Invest       Date:  2005-09-22       Impact factor: 14.808

3.  (5R)-5-hydroxytriptolide (LLDT-8) prevents collagen-induced arthritis through OPG/RANK/RANKL signaling in a rat model of rheumatoid arthritis.

Authors:  Ji-Zhou Zeng; Li-Feng Ma; Hai Meng; Hao-Miao Yu; Ya-Kui Zhang; Ai Guo
Journal:  Exp Ther Med       Date:  2016-09-21       Impact factor: 2.447

4.  Doxycycline attenuates peripheral inflammation in rat experimental autoimmune neuritis.

Authors:  Chenju Yi; Zhiyuan Zhang; Wei Wang; Caroline Zug; Hermann J Schluesener; Zhiren Zhang
Journal:  Neurochem Res       Date:  2011-06-08       Impact factor: 3.996

Review 5.  A review of applications of metabolomics in osteoarthritis.

Authors:  Jie-Ting Li; Ni Zeng; Zhi-Peng Yan; Tao Liao; Guo-Xin Ni
Journal:  Clin Rheumatol       Date:  2020-11-20       Impact factor: 2.980

6.  Static and dynamic compressive strains influence nitric oxide production and chondrocyte bioactivity when encapsulated in PEG hydrogels of different crosslinking densities.

Authors:  I Villanueva; D S Hauschulz; D Mejic; S J Bryant
Journal:  Osteoarthritis Cartilage       Date:  2008-01-18       Impact factor: 6.576

7.  Effect of mesenchymal stem cells combined with chondroitin sulfate in an in vitro model of osteoarthritis.

Authors:  Saúl Pérez-Castrillo; Maria Luisa González-Fernández; Jessica Álvarez-Suárez; Jaime Sánchez-Lázaro; Marta Esteban-Blanco; Laura Gutiérrez-Velasco; Elsa González-Cubero; Vega Villar-Suárez
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

8.  Peroxynitrite-dependent activation of protein phosphatase type 2A mediates microvascular endothelial barrier dysfunction.

Authors:  Feng Wu; John X Wilson
Journal:  Cardiovasc Res       Date:  2008-09-13       Impact factor: 10.787

9.  Novel functional aspect of antihistamines: the impact of bepotastine besilate on substance p-induced events.

Authors:  Shun Kitaba; Hiroyuki Murota; Yoko Yahata; Hiroaki Azukizawa; Ichiro Katayama
Journal:  J Allergy (Cairo)       Date:  2009-06-21

10.  PPARalpha agonists inhibit nitric oxide production by enhancing iNOS degradation in LPS-treated macrophages.

Authors:  E-L Paukkeri; T Leppänen; O Sareila; K Vuolteenaho; H Kankaanranta; E Moilanen
Journal:  Br J Pharmacol       Date:  2007-09-24       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.